Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Digestive system drugs>Cholagogue Drugs>Lithocholic acid
Lithocholic acid
  • Lithocholic acid

Lithocholic acid NEW

Price $29
Package 1mL
Min. Order:
Supply Ability: 10g
Update Time: 2025-12-04

Product Details

Product Name: Lithocholic acid CAS No.: 434-13-9
Purity: 99.98% Supply Ability: 10g
Release date: 2025/12/04

Product Introduction

Bioactivity

NameLithocholic acid
DescriptionLithocholic acid (3α-Hydroxy-5β-cholanic acid) is a toxic secondary bile acid, They were FXR antagonists (IC50=0.7, 1.4 μM), EphA2 antagonists (IC50=48, 66 μM) and EphB4 antagonists (IC50=141 μM). Lithocholic acid can promote intrahepatic cholestasis and promote tumorigenesis. Lithocholic acid is a cleanser that dissolves fat for absorption and is itself absorbed.
Kinase AssayCompetitive ligand binding assay.: Ligand binding is performed using lysates from COS-7 cells transfected with expression plasmids for VDR or RXRα. Binding is performed overnight at 4°C in lysate buffer with 0.71 nM (18 Ci/mmol) [3H]1,25(OH)2D3 and bile acid competitor. Unbound [3H]1,25(OH)2D3 is removed by adsorption to dextran-coated charcoal and the supernatant removed for scintillation counting. Ki values are calculated from a computer fit of competition curves from triplicate assays.
In vitroMETHODS: Human A549, HCT-116, HT-29, Huh-7, LoVo, MGC-803, RKO, SK-HEP1, SW480 cells were treated with Lithocholic acid (200, 100, 50, P < 0.05). 25, 12.5, 6.25, 3.125, 1.5625 μM) were used to detect the cell growth inhibition by MTT method. RESULTS: Lithocholic acid did not affect the growth of A549, HCT-116, HT-29, Huh-7, LoVo, MGC-803, RKO, SK-HEP1, and SW480 cells (IC50> 200 µM). [1] METHODS: Human Caco2 and HT-1080 cells were treated with Lithocholic acid (0.1-1000 μM) for 24 hours, and the cytotoxicity was detected by MTT assay. RESULTS: Lithocholic acid significantly inhibited the growth of Caco2 (IC50=56 μM) and HT-1080 cells (IC50=23 μM). [2] METHODS: Human DLD1, HCT-116, and HCT-8 cells were treated with Lithocholic acid (25, 50, 100, 150, and 200μM) for 48 hours, and the cytotoxicity was detected by MTT assay. RESULTS: Lithocholic acid significantly inhibited the growth of human DLD1 (IC50=173.1 μM), HCT-116 (IC50=81.1 μM) and HCT-8 (IC50=97.4 μM) cells. [3]
In vivoMETHODS: To investigate the antiviral effect of Lithocholic acid, Lithocholic acid oleate (3%) and Lithocholic acid (0.5%), derivatives of LCA, were administered to HSV-1 virus infected mice. RESULTS: Mice treated with Lithocholic acid oleate+Lithocholic acid 48 hours before virus inoculation showed lesions on day 6 after infection, and the wound healing was better than that of the acyclovir treatment group, with reduced scar formation and better skin repair. [4]
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationEthanol : 44 mg/mL (116.84 mM), Sonication is recommended.
DMSO : 49 mg/mL (130.12 mM), Sonication is recommended.
H2O : < 1 mg/mL (insoluble or slightly soluble)
KeywordsVD | PXR | Lithocholic acid | Inhibitor | inhibit | FXR | EndogenousMetabolite | Endogenous Metabolite | Autophagy | Apoptosis | 3alpha-Hydroxy-5beta-cholanic acid | 3a-Hydroxy-5b-cholanic acid
Inhibitors RelatedSucrose | Aceglutamide | L-Pyroglutamic acid | Emtricitabine | Levulinic acid | D(+)-Raffinose pentahydrate | D-(+)-Trehalose dihydrate | Glycerol | Thymidine | Gluconate Calcium | Ovalbumins | Chitosan oligosaccharide
Related Compound LibrariesAnti-Tumor Natural Product Library | Apoptosis Compound Library | Approved Drug Library | Natural Product Library | Microbial Natural Product Library | Natural Product Library for HTS | FDA-Approved Drug Library | RO5 Drug-like Natural Product Library | Metabolism Compound Library | Anti-Aging Compound Library | Human Endogenous Metabolite Compound Library Plus | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1KG
VIP2Y
Watson Biotechnology Co.,Ltd
2025-09-17
$0.00/1kg
VIP2Y
HANGZHOU HAILAN CHEMICAL CO.,LTD.
2025-09-08
$0.00/1KG
VIP2Y
Shaanxi Xianhe Biotech Co., Ltd
2025-04-18
$6.00/1kg
HebeiShuoshengImportandExportco.,Ltd
2024-08-09
$5.00/1KG
Hebei Longbang Technology Co., Ltd
2024-05-13
$0.00/1kg
Hebei Jingbo New Material Technology Co., Ltd
2024-01-05
$120.00/1kg
Wuhan Quanjinci New Material Co.,Ltd.
2023-11-09
$0.00/1KG
VIP4Y
Xinyi Dajiang Chemical Co.,Ltd.
2022-05-25
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
$0.00/20mg
Shanghai Standard Technology Co., Ltd.
2019-12-12

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY